RhumbLine Advisers’s Sagimet Biosciences SGMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-6,111
| Closed | -$20.9K | – | 4318 |
|
|
2024
Q2 | $20.9K | Sell |
6,111
-6,706
| -52% | -$22.9K | ﹤0.01% | 3865 |
|
|
2024
Q1 | $69.5K | Buy |
12,817
+7,513
| +142% | +$40.7K | ﹤0.01% | 3549 |
|
|
2023
Q4 | $28.7K | Sell |
5,304
-186
| -3% | -$1.01K | ﹤0.01% | 3722 |
|
|
2023
Q3 | $48.3K | Buy |
+5,490
| New | +$48.3K | ﹤0.01% | 3648 |
|